Comments on: Novartis Employee Blows Whistle And Gets Fired http://www.pharmalot.com/2007/11/novartis-employee-blows-whistle-and-gets-fired/ News, Comment and Conversation Fri, 10 Feb 2012 20:42:19 +0000 http://wordpress.org/?v=2.6.2 By: BP http://www.pharmalot.com/2007/11/novartis-employee-blows-whistle-and-gets-fired/#comment-29061 BP Tue, 27 Nov 2007 22:30:13 +0000 http://www.pharmalot.com/2007/11/novartis-employee-blows-whistle-and-gets-fired/#comment-29061 If Vasella has a headache, perhaps it's his conscience pounding on his id! No, not likely. Big pharma can't be trusted now. What would it be like if they had free rein? Chaos and anarchy! If Vasella has a headache, perhaps it’s his conscience pounding on his id! No, not likely. Big pharma can’t be trusted now. What would it be like if they had free rein? Chaos and anarchy!

]]> By: Angry http://www.pharmalot.com/2007/11/novartis-employee-blows-whistle-and-gets-fired/#comment-29026 Angry Tue, 27 Nov 2007 19:03:08 +0000 http://www.pharmalot.com/2007/11/novartis-employee-blows-whistle-and-gets-fired/#comment-29026 Novartis chief denounces U.S. corporate governance rules Daniel Vasella, chief executive of Novartis, the Swiss drugs maker, said U.S. corporate-governance rules were a “headache.” Vasella told the Associated Press news agency that new rules enacted in Washington following the series of high-profile accounting scandals were “onerous” for any company, such as Novartis, that does business in the U.S. “It’s a real headache from the point of view of the sheer [number of rules],” Vasella said on Monday. Vasella joins the ranks of executives of multinational companies who argue the new rules come with hefty time and money costs. The latest regulations, including the Sarbanes-Oxley Act of 2002, set stringent corporate-governance rules to protect minority shareholders’ rights, define clear divisions of responsibility within companies and dictate safeguards to prevent abuse. “Sarbanes-Oxley profoundly changed the way we talk, and the amount we’re spending – the amount of time and of course the millions [of dollars],” Vasella said. The Sarbanes-Oxley Act requires companies to document and test their internal checks governing business processes, such as payroll and accounts. “It is the nature of the beast that each time we have a scandal, regulation goes up,” Vasella said. “It is very tough to go down. I don’t think we should push it further.” Vasella, who holds both the chief executive and chairman positions at Novartis, said that although corporate governance activists were urging companies to split those two roles, he saw no problem with one person holding both positions. “I think that inherently there’s nothing wrong, provided that it fits the company at the stage at which the company finds itself,” Vasella said. Novartis chief denounces U.S. corporate governance rules
Daniel Vasella, chief executive of Novartis, the Swiss drugs maker, said U.S. corporate-governance rules were a “headache.”
Vasella told the Associated Press news agency that new rules enacted in Washington following the series of high-profile accounting scandals were “onerous” for any company, such as Novartis, that does business in the U.S.

“It’s a real headache from the point of view of the sheer [number of rules],” Vasella said on Monday.

Vasella joins the ranks of executives of multinational companies who argue the new rules come with hefty time and money costs.

The latest regulations, including the Sarbanes-Oxley Act of 2002, set stringent corporate-governance rules to protect minority shareholders’ rights, define clear divisions of responsibility within companies and dictate safeguards to prevent abuse.

“Sarbanes-Oxley profoundly changed the way we talk, and the amount we’re spending – the amount of time and of course the millions [of dollars],” Vasella said.

The Sarbanes-Oxley Act requires companies to document and test their internal checks governing business processes, such as payroll and accounts.

“It is the nature of the beast that each time we have a scandal, regulation goes up,” Vasella said. “It is very tough to go down. I don’t think we should push it further.”

Vasella, who holds both the chief executive and chairman positions at Novartis, said that although corporate governance activists were urging companies to split those two roles, he saw no problem with one person holding both positions.

“I think that inherently there’s nothing wrong, provided that it fits the company at the stage at which the company finds itself,” Vasella said.

]]> By: Disgusted http://www.pharmalot.com/2007/11/novartis-employee-blows-whistle-and-gets-fired/#comment-29016 Disgusted Tue, 27 Nov 2007 18:13:53 +0000 http://www.pharmalot.com/2007/11/novartis-employee-blows-whistle-and-gets-fired/#comment-29016 For many on the Big Pharma senior management teams, there is no Lord - only money! They sold their souls to the devil long ago and should get a good taste of the inferno! Unfortunately, firing good employees for doing the right thing is all too common. The serpents never die, they just slither on to the next company. For many on the Big Pharma senior management teams, there is no Lord - only money! They sold their souls to the devil long ago and should get a good taste of the inferno! Unfortunately, firing good employees for doing the right thing is all too common. The serpents never die, they just slither on to the next company.

]]> By: Afriend http://www.pharmalot.com/2007/11/novartis-employee-blows-whistle-and-gets-fired/#comment-28938 Afriend Tue, 27 Nov 2007 10:59:06 +0000 http://www.pharmalot.com/2007/11/novartis-employee-blows-whistle-and-gets-fired/#comment-28938 Wonder if this has anything to do with all of those senior managers who recently "left" Novartis? Shull has a lot of integrity and guts to take on Novartis--no one should be asked to lie...or be fired for doing the right thing. Wonder if this has anything to do with all of those senior managers who recently “left” Novartis? Shull has a lot of integrity and guts to take on Novartis–no one should be asked to lie…or be fired for doing the right thing.

]]> By: Jack http://www.pharmalot.com/2007/11/novartis-employee-blows-whistle-and-gets-fired/#comment-28925 Jack Tue, 27 Nov 2007 09:21:08 +0000 http://www.pharmalot.com/2007/11/novartis-employee-blows-whistle-and-gets-fired/#comment-28925 Those big pharmacy companies always care their wallet than the patients needs. They hire the staff to help them get more money, but for caring the patients. As for the medicine produced by Famvir. I personally have nothing to say because I never use it. I only know a member at STD dating site pozgroup.com said it works better than Valtrex in his blog. Not sure it true. Those big pharmacy companies always care their wallet than the patients needs. They hire the staff to help them get more money, but for caring the patients. As for the medicine produced by Famvir. I personally have nothing to say because I never use it. I only know a member at STD dating site pozgroup.com said it works better than Valtrex in his blog. Not sure it true.

]]> By: David Olagunju http://www.pharmalot.com/2007/11/novartis-employee-blows-whistle-and-gets-fired/#comment-28868 David Olagunju Tue, 27 Nov 2007 00:11:09 +0000 http://www.pharmalot.com/2007/11/novartis-employee-blows-whistle-and-gets-fired/#comment-28868 I told you so! More to come unless FDA and Congress put a break on evil deeds. May the Lord forgive them all. I told you so! More to come unless FDA and Congress put a break on evil deeds. May the Lord forgive them all.

]]> By: Disgusted http://www.pharmalot.com/2007/11/novartis-employee-blows-whistle-and-gets-fired/#comment-28848 Disgusted Mon, 26 Nov 2007 22:10:48 +0000 http://www.pharmalot.com/2007/11/novartis-employee-blows-whistle-and-gets-fired/#comment-28848 Big Pharma misdeeds like the one described above are unfortunately very commonplace. There is no room for honesty. If you don't blindly toe the company line, then you put your job in grave danger. If you disagree with senior management, then you're banished. In many cases, it seems like Putin and Russia! It really stinks that ethics means little to nothing in today's Big pharma culture. After they got rid of Ms. Shull, they probably blamed her for the failure to deliver and the need to take the write-off. That's how it works! Big Pharma misdeeds like the one described above are unfortunately very commonplace. There is no room for honesty. If you don’t blindly toe the company line, then you put your job in grave danger. If you disagree with senior management, then you’re banished. In many cases, it seems like Putin and Russia!

It really stinks that ethics means little to nothing in today’s Big pharma culture. After they got rid of Ms. Shull, they probably blamed her for the failure to deliver and the need to take the write-off. That’s how it works!

]]>